HN user

jandom

62 karma
Posts7
Comments12
View on HN

It’s likely an impossible choice, between inept big four consultancy groups (that charge $$$, deliver little, and run everything through manual excel entry) vs palantir who likely will deliver results. I have no love for Palantir but at least they’re competent.

During covid, palantir had to elbow its way to sell to the UK govt and replaced dilapidated “solutions” from the big four.

Isn't that being a little optimistic? After all if this was good news, it wouldn't be news :-)

Fully appreciating the point: antibody response is not the only response of the immune system.

The other story on HN right now is "AstraZeneca vaccine doesn't prevent B1351 Covid in early trial" – a finding consistent with the results of this study (yes, yes, AZ vaccine != Pfizer/Moderna).

https://www.cidrap.umn.edu/news-perspective/2021/03/astrazen...

So what becomes interesting is: does the AZ vaccine not produce the same T-cell response as Pfizer/Moderna, or are these vaccines in fact broadly similar (mutants don't affect T-cells but affect antibodies). The latter wouldn't be consistent with Skelly 2021.